Algert Global LLC Neuronetics, Inc. Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.81 - $6.71 $15,145 - $36,166	5,390 Added 43.68%	17,730 $52,000
Q4 2022 Feb 13, 2023	BUY	$2.74 - $6.87 $33,811 - $84,775	12,340 New	12,340 $85,000
Q2 2022 Aug 15, 2022	BUY	$2.09 - $3.71 $10,052 - $17,845	4,810 Added 35.82%	18,240 $59,000
Q1 2022 May 16, 2022	BUY	$2.84 - $4.52 $38,141 - $60,703	13,430 New	13,430 $41,000
Q1 2021 May 14, 2021	SELL	$10.6 - $21.27 $135,287 - $271,469	-12,763 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$1.41 - $2.61 $7,162 - $13,258	-5,080 Reduced 28.47%	12,763 $25,000
Q1 2020 May 13, 2020	BUY	$1.28 - $4.5 $22,839 - $80,293	17,843 New	17,843 $34,000

18.3M

3.8K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $20.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.